These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 23266466
1. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J. Eur J Pharm Sci; 2013 Feb 14; 48(3):393-405. PubMed ID: 23266466 [Abstract] [Full Text] [Related]
2. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method. Md S, Haque S, Fazil M, Kumar M, Baboota S, Sahni JK, Ali J. Expert Opin Drug Deliv; 2014 Jun 14; 11(6):827-42. PubMed ID: 24655115 [Abstract] [Full Text] [Related]
3. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Jafarieh O, Md S, Ali M, Baboota S, Sahni JK, Kumari B, Bhatnagar A, Ali J. Drug Dev Ind Pharm; 2015 Jun 14; 41(10):1674-81. PubMed ID: 25496439 [Abstract] [Full Text] [Related]
5. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. Raj R, Wairkar S, Sridhar V, Gaud R. Int J Biol Macromol; 2018 Apr 01; 109():27-35. PubMed ID: 29247729 [Abstract] [Full Text] [Related]
6. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route. Mittal D, Md S, Hasan Q, Fazil M, Ali A, Baboota S, Ali J. Drug Deliv; 2016 Apr 01; 23(1):130-9. PubMed ID: 24786489 [Abstract] [Full Text] [Related]
9. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Wang X, Chi N, Tang X. Eur J Pharm Biopharm; 2008 Nov 01; 70(3):735-40. PubMed ID: 18684400 [Abstract] [Full Text] [Related]
10. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation. Haque S, Md S, Fazil M, Kumar M, Sahni JK, Ali J, Baboota S. Carbohydr Polym; 2012 Jun 05; 89(1):72-9. PubMed ID: 24750606 [Abstract] [Full Text] [Related]
16. Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice. Sunena, Singh SK, Mishra DN. Curr Drug Deliv; 2019 Jun 05; 16(1):51-58. PubMed ID: 30289074 [Abstract] [Full Text] [Related]
18. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ". Shah B, Khunt D, Misra M, Padh H. Int J Biol Macromol; 2016 Aug 05; 89():206-18. PubMed ID: 27130654 [Abstract] [Full Text] [Related]
19. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation. Javia A, Thakkar H. J Microencapsul; 2017 Nov 05; 34(7):644-658. PubMed ID: 28862072 [Abstract] [Full Text] [Related]
20. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers. Mandlik SK, Ranpise NS, Mohanty BS, Chaudhari PR. Drug Deliv Transl Res; 2018 Jun 05; 8(3):797-805. PubMed ID: 29380155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]